Focused on Fungal disease covering prominent targets and the potent compounds

Anmol Pal

CYP51, Squalene epoxidase, Drug targets, Antifungal, Fluconazole

In individuals with immunocompromised system, fungal infection is a common problem that frequently result in high rates of morbidity and mortality. Five separate antifungal drug classes are used in current therapy, four of which concentrate on ergosterol and cell wall glucan production. However, there are several disadvantages to using the antifungals that are now on the market, including poor oral bioavailability, limited therapeutic indices, and the development of drug resistance as a result of their use. Recent improvements in the research and development of antifungal drugs can be seen in the appearance of several novel compounds that are now in various phases of development.

Published Paper   E-Certificate

"Focused on Fungal disease covering prominent targets and the potent compounds", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.8, Issue 3, page no.743 - 746, March-2023, Available :https://ijsdr.org/papers/IJSDR2303119.pdf

Volume 8 Issue 3, March-2023

Pages : 743 - 746

Paper Reg. ID: IJSDR_204500

Published Paper Id: IJSDR2303119

Downloads: 000347167

Research Area: Pharmacy

Country: Bhopal, Raisen, Madhya Pradesh, India

Published Paper PDF: https://ijsdr.org/papers/IJSDR2303119

Published Paper URL: https://ijsdr.org/viewpaperforall?paper=IJSDR2303119

ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJSDR(IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition